Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyn Morice

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
ERJ Open Research|February 11, 2025
Cough frequency has a high daily variation in patients with chronic coughAlyn Morice, Mitja Alge, Laura Kuett, et al.
ERJ Open Research|May 5, 2022
Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoringMengru Zhang, Kayleigh Brindle, Melanie Robinson, et al.
Journal of Cardiac Failure|October 25, 2002
Airway resistance in chronic heart failure measured by impulse oscillometryKlaus K A Witte, Alyn Morice, Andrew L Clark, et al.
Pulmonary Pharmacology & Therapeutics|January 13, 2009
Semantics and types of coughKian Fan Chung, Don Bolser, Paul Davenport, et al.
Journal of Cardiac Failure|April 22, 2004
The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometryKlaus K A Witte, Alyn Morice, John G F Cleland, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 7, 2017
The differential effects of systemic vasoconstrictors on human pulmonary artery tensionAzar Hussain, Rob Bennett, Yama Haqzad, et al.
Respiratory Medicine|February 8, 2018
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levelsJohn Haughney, Alyn Morice, Kevin G Blyth, et al.
British Journal of Clinical Pharmacology|May 22, 2024
Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young menChristian Friedrich, Dave Singh, Klaus Francke, et al.
Current Medical Research and Opinion|September 28, 2019
Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?Sarah E Holden, Alyn Morice, Surinder S Birring, et al.
Clinical Pharmacokinetics|May 27, 2022
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized StudyChristian Friedrich, Klaus Francke, Isabella Gashaw, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
ERJ Open Research|February 11, 2025
Cough frequency has a high daily variation in patients with chronic coughAlyn Morice, Mitja Alge, Laura Kuett, et al.
ERJ Open Research|May 5, 2022
Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoringMengru Zhang, Kayleigh Brindle, Melanie Robinson, et al.
Journal of Cardiac Failure|October 25, 2002
Airway resistance in chronic heart failure measured by impulse oscillometryKlaus K A Witte, Alyn Morice, Andrew L Clark, et al.
Pulmonary Pharmacology & Therapeutics|January 13, 2009
Semantics and types of coughKian Fan Chung, Don Bolser, Paul Davenport, et al.
Journal of Cardiac Failure|April 22, 2004
The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometryKlaus K A Witte, Alyn Morice, John G F Cleland, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 7, 2017
The differential effects of systemic vasoconstrictors on human pulmonary artery tensionAzar Hussain, Rob Bennett, Yama Haqzad, et al.
Respiratory Medicine|February 8, 2018
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levelsJohn Haughney, Alyn Morice, Kevin G Blyth, et al.
British Journal of Clinical Pharmacology|May 22, 2024
Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending-dose study in healthy young menChristian Friedrich, Dave Singh, Klaus Francke, et al.
Current Medical Research and Opinion|September 28, 2019
Cough presentation in primary care and the identification of chronic cough: a need for diagnostic clarity?Sarah E Holden, Alyn Morice, Surinder S Birring, et al.
Clinical Pharmacokinetics|May 27, 2022
Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized StudyChristian Friedrich, Klaus Francke, Isabella Gashaw, et al.
Pageof 5